Skip to main content

Animations

MJFF Publications

3761 - 3770 of 8824 Results
Title
Year
  • Year
  • 2025
  • 2025
  • 2025
  • 2024
  • 2025
  • 2024
  • 2024
  • 2025
  • 2025
  • 2025
  • Summary Details
    OPEN
    Title: Alpha-synuclein regulates nucleolar DNA double-strand break repair in melanoma
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1126/sciadv.adq2519
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Transcriptomic responses of lung mesenchymal cells during pneumonia
    Journal Name: JCI Insight
    Publisher: American Society for Clinical Investigation
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1172/jci.insight.177084
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Spatial genomics of AAV vectors reveals mechanism of transcriptional crosstalk that enables targeted delivery of large genetic cargo
    Journal Name: Nature Biotechnology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41587-025-02565-4
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Dopamine D1–D5 Receptors in Brain Nuclei: Implications for Health and Disease
    Journal Name: Receptors
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/receptors3020009
    Citation Count: 42
  • Summary Details
    OPEN
    Title: Characterizing the expression profile of 3R tau pathology in Pick’s disease
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1126/sciadv.adt6105
    Citation Count: 2
  • Summary Details
    OPEN
    Title: P2RX7, an adaptive immune response gene, is associated with Parkinson's disease risk and age at onset
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1177/1877718x241296015
    Citation Count: 1
  • Summary Details
    OPEN
    Title: New insights from a Malaysian real-world deep brain stimulation cohort
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1177/1877718x241297715
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Use of β-adrenoreceptor drugs and Parkinson’s disease incidence in women from the French E3N cohort study
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1177/1877718x251330993
    Citation Count: 1
  • Summary Details
    OPEN
    Title: A framework to standardize gait study protocols in Parkinson's disease
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1177/1877718x241305626
    Citation Count: 11
  • Summary Details
    OPEN
    Title: A single-cell atlas to map sex-specific gene-expression changes in blood upon neurodegeneration
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-025-56833-7
    Citation Count: 8
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.